Work for Oncolytics Biotech Inc.?

Claim Your Profile

Oncolytics Biotech Inc. Logo Image

Oncolytics Biotech Inc.

Oncolytics Biotech Inc. Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2019 Annual Report

Oncolytics Biotech Inc.

Oncolytics Biotech Inc. has reached its limit for free report views.

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

Archived Annual Reports

About Oncolytics Biotech Inc.

11-50 Employees
Based in Calgary, Alberta

Oncolytics Biotech Inc. is developing pelareorep, a safe and well-tolerated intravenously delivered immuno-oncolytic virus (IOV) that targets cancer through a unique mechanism of action with two components, selective tumor lysis and activation of the innate and adaptive immune systems, creating an inflamed phenotype to treat a variety of solid tumors and hematological malignancies.

Ticker:
ONC
Exchange:
TSX (See More TSX Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol